{"meta":{"query_hash":"84ff8c089e7c","filters":{"venue":"Journal of Cancer Immunology"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/84ff8c089e7c","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Cancer+Immunology"},"results":[{"id":"W4404740547","doi":"10.33696/cancerimmunol.6.094","title":"Phosphopeptide Neoantigens as Emerging Targets in Cancer Immunotherapy","year":2024,"lang":"en","type":"article","venue":"Journal of Cancer Immunology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; York University","keywords":"Phosphopeptide; Cancer immunotherapy; Immunotherapy; Cancer; Cancer research; Medicine; Computational biology; Biology; Internal medicine; Cell biology; Phosphorylation","score_opus":0.021621070642528675,"score_gpt":0.3901002021246143,"score_spread":0.36847913148208566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404740547","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7492481,0.18178383,0.031614047,0.0053075654,0.0011548699,0.00019383518,0.00028611653,0.00028615462,0.030125441],"genre_scores_gemma":[0.9185182,0.06460957,0.008667615,0.0010196787,0.00057748205,0.00008199918,0.00020020115,0.00002302494,0.0063022044],"study_design_codex":"bench_or_experimental","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9998851,0.000039318307,0.0000059608024,0.000013563197,0.00003652524,0.0000195579],"domain_scores_gemma":[0.99993825,0.000018530929,0.000010243133,0.0000042579168,0.0000075252265,0.00002116803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034194707,0.00025372035,0.00020984127,0.00023652901,0.00011594488,0.00057100214,0.00023377803,0.000343986,0.0021861817],"category_scores_gemma":[0.00016257125,0.00012067864,0.00010817173,0.00018035772,0.00023637142,0.0005257131,0.00029676914,0.0008713587,0.00061537477],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008078485,0.00040157497,0.0029217082,0.000708967,0.000043523738,0.00095815805,0.00007919366,0.0016684649,0.6783388,0.012478742,0.002874669,0.29871836],"study_design_scores_gemma":[0.0008829927,0.011526176,0.017430011,0.00047920342,0.00025477013,0.011953678,0.00038171266,0.016114643,0.6568999,0.024000172,0.2600301,0.00004657562],"about_ca_topic_score_codex":0.00004994305,"about_ca_topic_score_gemma":0.00012640635,"teacher_disagreement_score":0.0021861817,"about_ca_system_score_codex":0.00017042547,"about_ca_system_score_gemma":0.00022708211,"threshold_uncertainty_score":0.00731349},"labels":[],"label_agreement":null}]}